MDxHealth Gelecekteki Büyüme

Future kriter kontrolleri 1/6

MDxHealth is forecast to grow earnings and revenue by 36.1% and 12.3% per annum respectively while EPS is expected to grow by 42.3% per annum.

Anahtar bilgiler

36.1%

Kazanç büyüme oranı

42.3%

EPS büyüme oranı

Biotechs kazanç büyümesi27.1%
Gelir büyüme oranı12.3%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme15 Oct 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

NasdaqCM:MDXH - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/2026108-16683
12/31/202597-22-7-35
12/31/202484-35-20-165
6/30/202481-41-25-21N/A
3/31/202475-40-27-23N/A
12/31/202370-43-27-21N/A
9/30/202364-45-30-24N/A
6/30/202355-48-35-29N/A
3/31/202346-47-34-30N/A
12/31/202237-44-38-34N/A
9/30/202230-40-32-30N/A
6/30/202225-34-28-26N/A
3/31/202223-31N/AN/AN/A
12/31/202122-29-23-23N/A
9/30/202121-28-22-21N/A
6/30/202119-28-21-21N/A
3/31/202119-28N/AN/AN/A
12/31/202018-29-21-20N/A
9/30/202015-36-20-20N/A
6/30/202011-43-20-20N/A
3/31/202011-43-21-21N/A
12/31/201912-43-22-22N/A
9/30/201917-37-25-25N/A
6/30/201922-31-28-27N/A
3/31/201925-32-29-28N/A
12/31/201828-32-30-29N/A
9/30/201831-30-30-28N/A
6/30/201833-28-31-27N/A
3/31/201837-20N/A-19N/A
12/31/201741-12N/A-10N/A
9/30/201741-9N/A-8N/A
6/30/201741-5N/A-5N/A
3/31/201736-9N/A-11N/A
12/31/201630-13N/A-17N/A
9/30/201626-15N/A-17N/A
6/30/201623-17N/A-16N/A
3/31/201620-16N/A-15N/A
12/31/201518-14N/A-14N/A
9/30/201516-14N/A-15N/A
6/30/201515-13N/A-15N/A
3/31/201513-14N/A-17N/A
12/31/201412-15N/A-19N/A
9/30/201410-16N/A-19N/A
6/30/20148-16N/A-19N/A
3/31/20148-16N/A-17N/A
12/31/20138-16N/A-14N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: MDXH is forecast to remain unprofitable over the next 3 years.

Kazançlar ve Piyasa: MDXH is forecast to remain unprofitable over the next 3 years.

Yüksek Büyüme Kazançları: MDXH is forecast to remain unprofitable over the next 3 years.

Gelir ve Pazar: MDXH's revenue (12.3% per year) is forecast to grow faster than the US market (8.9% per year).

Yüksek Büyüme Geliri: MDXH's revenue (12.3% per year) is forecast to grow slower than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if MDXH's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin